This Solicitation opportunity from Department Of Defense was posted on July 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
ZOLMITRIPTAN TABLET
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Zolmitriptan tablets, 2.5 mg, are rapidly disintegrating tablets individually sealed in blister packs, intended for the treatment of migraines, with a unit of issue defined as a package of six tablets. The product is classified under the American Hospital Formulary Service code 28:92.00 and must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from light and moisture, and dispensed in a tight, light-resistant closed container. The item is regulated by the FDA and carries a non-extendable shelf life of 36 months as a Type I (Code Q) item under RS001 requirements. Packaging must comply with MIL-STD-2073-1E and the latest edition of the Medical Marking Standard No. 1, with government identification removed from non-accepted supplies as per RQ011. The contract specifies two manufacturers: AVKARE LLC with NDC 42291-0998-06 and JUBILANT CADISTA PHARMACEUTICALS INC. with NDC 59746-0461-16, and the item is identified by NSN 6505-01-523-0353. The procurement is governed under solicitation SPE2DP-26-T-4105, requiring delivery of six packages within 20 days, FOB destination, with no variance allowed in quantity. Inspection and acceptance occur at the delivery point. Technical and quality requirements referenced by R and I numbers are incorporated from the DLA Master List of Technical and Quality Requirements, with applicable revisions determined by the solicitation or award date. All contracting actions must include referral to the product specialist via EBS with full manufacturer and bidder details.
General Info
Agency
NAICS
Place of Performance
BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
ZOLMITRIPTAN TABLETS, 2.5 MG, 6'S
.
2.5 MG, RAPIDLY DISINTEGRATING TABLETS, INDIVIDUALLY SEALED; BLISTER
PACK; USED IN TREATMENT OF MIGRAINES. AMERICAN HOSPITAL FORMULARY
SERVICE CLASSIFICATION NUMBER: 28:92.00.
.
UNIT OF ISSUE: PACKAGE (PG) OF 6EA
.
STORE AT 20°C TO 25°C (68°F TO 77°F) [SEE USP CONTROLLED ROOM
TEMPERATURE]. PROTECT FROM LIGHT AND MOISTURE. DISPENSE IN A TIGHT,
LIGHT-RESISTANT CLOSED CONTAINER.
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . .. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
AVKARE LLC 4QGW8 P/N NDC42291-0998-06 JUBILANT CADISTA PHARMACEUTICALS INC. 441M0 P/N NDC59746-0461-16
TDP Rev A Gen 1 IAW REFERENCE REVISION NR DTD PART PIECE NUMBER:
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
SPE2DP-26-T-4105
SECTION B
PR: 7017467012 PRLI: 0001 CONT’D
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017467012 0001 PG 6.000
NSN/MATERIAL:6505015230353
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-523-0353 Quantity: 6 PG Purchase Request: 7017467012QTY: 6 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS